UPDATE: Marvell's (MRVL) Risk/Reward 'Skewing More Positive'; Morgan Stanley Upgrades to Overweight

Go back to UPDATE: Marvell's (MRVL) Risk/Reward 'Skewing More Positive'; Morgan Stanley Upgrades to Overweight

Brean Capital Maintains Buy on Marvell Technology (MRVL) Following Q1

May 22, 2015 7:41 AM EDT

Brean Capital maintains a Buy rating and $16 price target on Marvell (NASDAQ: MRVL) following April's quarter results. Analyst Mike Burton said that MRVL reported a 16% sequential decline in revenue, MRVL's 4th consecutive miss.

"Marvell reported April quarter results in line with their negative pre-announcement (off... More

Marvell (MRVL) PT, Estimates Cut at Susquehanna Post Q1, Cautious Outlook

May 22, 2015 6:46 AM EDT

Susquehanna analyst Chris Caso lowered his price target on Marvell (NASDAQ: MRVL) to $18.00 (from $20.00) following results and cautious guidance after the close but maintained a Positive rating.

Caso commented, "MRVL reported earnings last night, and guided the July quarter cautiously, about flat Q/Q, after the significant miss in April. We think there are three important elements... More

Cowen Trims PT on Marvell (MRVL) to $18 Following Q1 Results, Softer-than-Expected Q2 Outlook

May 22, 2015 6:38 AM EDT

Cowen and Company affirms its Outperform rating on Marvell Technology Group (Nasdaq: MRVL), but moves its price target from $19 to $18 following Q1 results and outlook issued after markets closed on Thursday.

Analyst Tim Arcuri noted that MRVL's Q116 EPS of $.13 topped the firm's $.11 estimate, while revnue was... More